Study of ZG005 in Combination With Gecacitinib in Patients With Relapsed or Refractory Lymphoma
Clinical trial NCT06883526 · RECRUITING
Trial details
- NCT number
- NCT06883526
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-16
- Primary completion
- 2027-04-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.